Cargando…

Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response

BACKGROUND: Receptor activator of nuclear factor κ B ligand (RANKL), osteoprotegerin (OPG), cartilage oligomeric matrix protein (COMP), bone morphogenetic protein (BMP-2), and fibroblast growth factor 23 (FGF-23) are involved in inflammation, calcium deposition, and fibrosis of blood vessels. Acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Da, Szeto, Wilson Y., Laudanski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847201/
https://www.ncbi.nlm.nih.gov/pubmed/36635948
http://dx.doi.org/10.12659/MSM.937934
_version_ 1784871405024706560
author Liu, Da
Szeto, Wilson Y.
Laudanski, Krzysztof
author_facet Liu, Da
Szeto, Wilson Y.
Laudanski, Krzysztof
author_sort Liu, Da
collection PubMed
description BACKGROUND: Receptor activator of nuclear factor κ B ligand (RANKL), osteoprotegerin (OPG), cartilage oligomeric matrix protein (COMP), bone morphogenetic protein (BMP-2), and fibroblast growth factor 23 (FGF-23) are involved in inflammation, calcium deposition, and fibrosis of blood vessels. Acute changes in these factors may contribute to the progression of arteriosclerosis, especially if their elevated serum levels persist postoperatively. MATERIAL/METHODS: A total of 90 patients (79 White, 4 African American, and 7 Other) undergoing elective heart surgery were enrolled in the study. Blood was collected before surgery and after surgery at 24 hours, 7 days, and 3 months to allow for longitudinal comparisons. After the plasma isolation, several biomarkers levels were studied using an enzymatic-linked assay. Demographic and clinical information were obtained from electronic health records. RESULTS: At 24 hours after surgery, RANKL (RANKL(baseline)=248.7±215.7 vs RANKL(t24h)=376.4±329.7; P=0.035), and BMP-2 (BMP-2(baseline)=283.7±255.4 vs BMP-2(t24h)=482.4; P=0.015) were significantly elevated compared to baseline, with levels returning to baseline at 7 days. FGF-23 increased significantly from baseline (FGF-23(baseline)=1020±1210) to 7 days (FGF-23(7d)=2191±5188; P=0.029) and remained significantly higher than baseline at 3 months (FGF-23(3m)=2041±3521; P=0.044). White blood cells (WBC) remained elevated at discharge (WBC(baseline)=6.8±2.1 vs WBC(24h)=15.0±5.3 vs WBC(discharge) =8.8±3.4). IL-8 and C-reactive protein normalized at 3 months. Estimated blood loss was significantly correlated with RANKL at 24 hours (r(2)=0.33; P=0.035). Serum creatinine levels after surgery at 24 hours (r(2)=0.41; p=0.008) and 7 days (r(2)=0.59; P=0.000) was strongly correlated with COMP. CONCLUSIONS: Persistent elevation of serum FGF-23 indicates a potential for accelerated arteriosclerosis after cardiac surgery.
format Online
Article
Text
id pubmed-9847201
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98472012023-01-27 Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response Liu, Da Szeto, Wilson Y. Laudanski, Krzysztof Med Sci Monit Clinical Research BACKGROUND: Receptor activator of nuclear factor κ B ligand (RANKL), osteoprotegerin (OPG), cartilage oligomeric matrix protein (COMP), bone morphogenetic protein (BMP-2), and fibroblast growth factor 23 (FGF-23) are involved in inflammation, calcium deposition, and fibrosis of blood vessels. Acute changes in these factors may contribute to the progression of arteriosclerosis, especially if their elevated serum levels persist postoperatively. MATERIAL/METHODS: A total of 90 patients (79 White, 4 African American, and 7 Other) undergoing elective heart surgery were enrolled in the study. Blood was collected before surgery and after surgery at 24 hours, 7 days, and 3 months to allow for longitudinal comparisons. After the plasma isolation, several biomarkers levels were studied using an enzymatic-linked assay. Demographic and clinical information were obtained from electronic health records. RESULTS: At 24 hours after surgery, RANKL (RANKL(baseline)=248.7±215.7 vs RANKL(t24h)=376.4±329.7; P=0.035), and BMP-2 (BMP-2(baseline)=283.7±255.4 vs BMP-2(t24h)=482.4; P=0.015) were significantly elevated compared to baseline, with levels returning to baseline at 7 days. FGF-23 increased significantly from baseline (FGF-23(baseline)=1020±1210) to 7 days (FGF-23(7d)=2191±5188; P=0.029) and remained significantly higher than baseline at 3 months (FGF-23(3m)=2041±3521; P=0.044). White blood cells (WBC) remained elevated at discharge (WBC(baseline)=6.8±2.1 vs WBC(24h)=15.0±5.3 vs WBC(discharge) =8.8±3.4). IL-8 and C-reactive protein normalized at 3 months. Estimated blood loss was significantly correlated with RANKL at 24 hours (r(2)=0.33; P=0.035). Serum creatinine levels after surgery at 24 hours (r(2)=0.41; p=0.008) and 7 days (r(2)=0.59; P=0.000) was strongly correlated with COMP. CONCLUSIONS: Persistent elevation of serum FGF-23 indicates a potential for accelerated arteriosclerosis after cardiac surgery. International Scientific Literature, Inc. 2023-01-13 /pmc/articles/PMC9847201/ /pubmed/36635948 http://dx.doi.org/10.12659/MSM.937934 Text en © Med Sci Monit, 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) )
spellingShingle Clinical Research
Liu, Da
Szeto, Wilson Y.
Laudanski, Krzysztof
Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response
title Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response
title_full Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response
title_fullStr Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response
title_full_unstemmed Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response
title_short Elevated Serum Fibroblast Growth Factor 23 (FGF-23) Perseveres into a Convalescence Period After Elective Cardiac Surgery, with Receptor Activator of Nuclear Factor κB Ligand (RANKL) and Cartilage Oligomeric Matrix Protein (COMP) Being Part of the Peri-Surgical Pro-Arteriosclerotic Inflammatory Response
title_sort elevated serum fibroblast growth factor 23 (fgf-23) perseveres into a convalescence period after elective cardiac surgery, with receptor activator of nuclear factor κb ligand (rankl) and cartilage oligomeric matrix protein (comp) being part of the peri-surgical pro-arteriosclerotic inflammatory response
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847201/
https://www.ncbi.nlm.nih.gov/pubmed/36635948
http://dx.doi.org/10.12659/MSM.937934
work_keys_str_mv AT liuda elevatedserumfibroblastgrowthfactor23fgf23perseveresintoaconvalescenceperiodafterelectivecardiacsurgerywithreceptoractivatorofnuclearfactorkbligandranklandcartilageoligomericmatrixproteincompbeingpartoftheperisurgicalproarterioscleroticinflammatoryrespons
AT szetowilsony elevatedserumfibroblastgrowthfactor23fgf23perseveresintoaconvalescenceperiodafterelectivecardiacsurgerywithreceptoractivatorofnuclearfactorkbligandranklandcartilageoligomericmatrixproteincompbeingpartoftheperisurgicalproarterioscleroticinflammatoryrespons
AT laudanskikrzysztof elevatedserumfibroblastgrowthfactor23fgf23perseveresintoaconvalescenceperiodafterelectivecardiacsurgerywithreceptoractivatorofnuclearfactorkbligandranklandcartilageoligomericmatrixproteincompbeingpartoftheperisurgicalproarterioscleroticinflammatoryrespons